2 days Abbott’s Q3 Earnings Release Coming Up, EPD Business in FocusZacks
ABT’s Neuromodulation growth is expected to have been driven by strong demand in international markets for the Eterna rechargeable spinal cord stimulation device.
Abbott Labs (ABT) · Business · Earnings
X